SQZ Biotechnologies Market Cap 2020-2023 | SQZ

SQZ Biotechnologies market cap history and chart from 2020 to 2023. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. SQZ Biotechnologies market cap as of June 06, 2023 is $0.02B.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.017B $0.021B
SQZ Biotechnologies Company is a clinical-stage biotechnology company. It develops transformative cell therapies for patients with cancer, infectious diseases and other serious conditions. The company's prime product candidate consist SQZ-PBMC-HPV which is in clinical stage. SQZ Biotechnologies Company is based In Watertown, Massachusetts.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $138.614B 8.47
GSK (GSK) United Kingdom $70.187B 9.79
Bio-Rad Laboratories (BIO.B) United States $10.988B 29.38
QIAGEN (QGEN) Netherlands $10.454B 22.07
Ginkgo Bioworks Holdings (DNA) United States $3.441B 0.00
Arcus Biosciences (RCUS) United States $1.502B 0.00
Biohaven (BHVN) United States $1.477B 0.00
Emergent Biosolutions (EBS) United States $0.399B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.200B 0.00
Enzo Biochem (ENZ) United States $0.110B 0.00